Outcome Measures | Endpoint |
---|---|
Primary | |
Self-reported data on social distancing, quarantine, social connectedness, healthcare utilization, well-being | The proportion of respondents who report adhering to social distancing guidelines after a test result for the entire study cohort and stratified by participant demographics (e.g., gender) of interest; comparison of proportion adherent after positive vs. negative test result |
Secondary | |
Self-reported data on awareness of the issue, engagement, decisions to act, action, and maintenance | The proportion of respondents who decide to act on precautionary behaviors after a test result for the entire study cohort and stratified by participant demographics (e.g., gender) of interest |
Self-reported emergency department visits, hospitalizations, and intensive care unit admission, for SARS CoV-2 evaluation or treatment | Point estimate and 95% confidence interval for each healthcare utilization measure and composite measure for the entire study cohort and stratified by participant demographics (e.g., gender) of interest |
Self-reported data on perceptions and prevention of risks of contracting SARS CoV-2 infection | The proportion of respondents who are knowledgeable of precautionary measures to prevent infection for the entire study cohort and stratified by participant demographics (e.g., gender) of interest |
Reported results of self-administered SARS CoV-2 antigen test | Prevalence of positive test results with 95% confidence intervals for the entire study cohort and stratified by participant demographic variables of interest |
Exploratory | |
Self-reported data on acceptability, practicality, integration, penetration, and demand of at-home self-administered antigen test | The proportion of respondents who find at-home self-administered antigen test acceptable for the entire study cohort and stratified by participant demographics (e.g., gender) of interest |
Mobility patterns as captured by surrogates, including activity trackers | Distribution of individual mobility data in response to positive vs. negative SARS CoV-2 test results |
Self-reported data on perceived susceptibility, severity, benefits, barriers, and cues to action related to SARS CoV-2 vaccination | Distribution of respondent’s perception about SARS CoV-2 vaccination for the entire study cohort and stratified by participant demographics (e.g., gender) of interest |